Cargando…

Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL

SIMPLE SUMMARY: In chronic lymphocytic leukemia (CLL), the interplay between the neoplastic clone and the tumor microenvironment largely contributes to leukemia survival, tumor propagation and drug resistance. A better understanding of the molecular circuits sustaining the biological effects of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitale, Candida, Griggio, Valentina, Riganti, Chiara, Todaro, Maria, Kopecka, Joanna, Jones, Rebecca, Salvetti, Chiara, Boccellato, Elia, Perutelli, Francesca, Voena, Claudia, Godio, Laura, Boccadoro, Mario, Coscia, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229189/ https://www.ncbi.nlm.nih.gov/pubmed/34207596 http://dx.doi.org/10.3390/cancers13122883

Ejemplares similares

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
por: Griggio, Valentina, et al.
Publicado: (2020)

Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs
por: Vitale, Candida, et al.
Publicado: (2020)

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
por: Vitale, Candida, et al.
Publicado: (2021)

Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
por: Vitale, Candida, et al.
Publicado: (2023)

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
por: Rigoni, Micol, et al.
Publicado: (2015)

CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
por: Vitale, Candida, et al.
Publicado: (2023)

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
por: Griggio, Valentina, et al.
Publicado: (2020)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
por: Castella, Barbara, et al.
Publicado: (2015)

Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
por: Dogliotti, Irene, et al.
Publicado: (2021)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
por: Salvetti, Chiara, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

CLL kinetics in the tumor microenvironment
por: Sun, Clare, et al.
Publicado: (2017)

Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
por: Gargiulo, Ernesto, et al.
Publicado: (2023)

Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
por: Riganti, Chiara, et al.
Publicado: (2013)

HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection
por: Liu, Ruining, et al.
Publicado: (2022)

NF-kB and the CLL microenvironment
por: O’Donnell, Alice, et al.
Publicado: (2023)

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy
por: Porrazzo, Marika, et al.
Publicado: (2020)

Publisher Correction: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection
por: Liu, Ruining, et al.
Publicado: (2022)

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
por: Tedeschi, Alessandra, et al.
Publicado: (2021)

ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
por: Salaroglio, Iris C., et al.
Publicado: (2019)

Endothelial Heme Dynamics Drive Cancer Cell Metabolism by Shaping the Tumor Microenvironment
por: Petrillo, Sara, et al.
Publicado: (2021)

ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy
por: Corsetto, Paola Antonia, et al.
Publicado: (2017)

IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
por: Roux, Cecilia, et al.
Publicado: (2021)

Programmed cell death in Saccharomyces cerevisiae is hampered by the deletion of GUP1 gene
por: Tulha, Joana, et al.
Publicado: (2012)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors
por: Kopecka, Joanna, et al.
Publicado: (2016)

Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models
por: Niso, Mauro, et al.
Publicado: (2021)

HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
por: Hammami, Akil, et al.
Publicado: (2018)

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
por: Griggio, Valentina, et al.
Publicado: (2016)

Crippled Children's Hampers
por: Treloar, W. P.
Publicado: (1906)

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
por: Salaroglio, Iris Chiara, et al.
Publicado: (2018)

Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
por: Akman, Muhlis, et al.
Publicado: (2021)

Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
por: Campani, Virginia, et al.
Publicado: (2022)

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
por: Bruch, Peter‐Martin, et al.
Publicado: (2022)

A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021)

Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells
por: Chung, Katherine Po Sin, et al.
Publicado: (2021)

Glioblastoma, from disease understanding towards optimal cell-based in vitro models
por: Boccellato, Chiara, et al.
Publicado: (2022)

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
por: Coscia, Marta, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2mrktc0b5r6cj4dii1ljcco21m